How does the cancer committee monitor the program's Estimated Performance Rates (EPR)?

• A. Patient surveys and feedback
• B. Accessing state health department records
• C. Using CP3R
• D. Manually reviewing patient charts

Answer: (C)

The monitoring of a cancer program's Estimated Performance Rates (EPR) is primarily conducted through the use of CP3R, which stands for the Commission on Cancer's (CoC) Cancer Programs Practice Report. CP3R is a data reporting tool that aggregates and analyzes performance measures from cancer programs to evaluate treatment outcomes and adherence to established standards of care.

Using CP3R allows the cancer committee to systematically review key performance indicators, compare those rates to national benchmarks, and identify areas for improvement within the program. This tool is integral to ensuring that cancer care provided at the institution meets the CoC standards and helps in improving the quality of care.

Other methods, such as patient surveys or accessing state health department records, may provide useful information about patient experiences and broader health trends but do not directly measure the specific performance rates required by the CoC. While manual chart reviews can provide insight into individual cases, they lack the comprehensive and standardized approach that CP3R offers for monitoring overall performance rates effectively.